IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Atlas Venture Associates IX, LLC

Q1 2019 Holdings

Filed 2019-05-13 | 7 holdings | $106.5K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Intellia Therapeutics Inc(NTLA)COM45826J105$27.6K1,615,32125.9%
Surface Oncology IncCOM86877M209$22.2K4,645,45320.8%
Synlogic IncCOM87166L100$20.1K2,651,96318.9%
Spero Therapeutics Inc(SPRO)COM84833T103$17.6K1,376,96816.6%
Unum Therapeutics IncCOM903214104$14.8K3,361,53513.9%
Carbon Black IncCOM14081R103$2.5K181,2732.4%
Snap Inc(SNAP)CL A83304A106$1.7K150,1601.6%